Congratulations to Dr. Nathaniel Bouganim for his appointment as the MUHC Division Director for Medical Oncology.
Dr. Nathaniel Bouganim is an Assistant Professor in the Gerald Bronfman Department of Oncology. He completed his training in internal medicine and oncology at 麻豆AV and his sub-specialty training in breast cancer, focusing on bone metastases and 鈥減atient centered care鈥� with Dr. Mark Clemons at the Ottawa Integrative Cancer Centre and the National Cancer Institute of Canada (NCIC).
He joined the 麻豆AV Health Centre (MUHC) in 2011 as a medical oncologist specializing in breast cancer and head and neck cancers. He currently serves as the Director of the Oncology in-patient teaching unit at the MUHC. Dr. Bouganim is a very active researcher with multiple investigator led clinical trials, and is principal investigator on numerous phase 1, 2 and 3 clinical trials in both breast and head and neck cancers. He is a founding member of the scientific committee for the McPeak Sirois group for clinical research in breast cancer as well as a member of the Comit茅 d'茅volution des pratiques en oncologie (CEPO) guideline committee. In addition, he has served as a breast cancer expert for Quebec鈥檚 Institut national d鈥檈xcellence en sant茅 et en services sociaux (INESS).